ABSTRACT Using H,15O (half- 
with H2150. O is an attractive tracer for this purpose since its short half-life of 2.1 min permits rapid sequential measurements and since water can be labeled easily with '10. Both considerations are critical in the clinical application of sequential perfusion measurements.
Although the myocardial cell is highly permeable to H20, the presence of membranes could, theoretically, limit diffusibility. Rose et al. ' 8 and others`9 have suggested the existence of barriers to free diffusibility at the capillary and sarcolemmal levels. 18 . 19 On the other hand, membrane permeability appears to be high enough in the heart (in contrast to the brain20) so that the distribution of H,0 at physiologic flows is flow rather than diffusion limited. 2'-23 Results in the present study obtained in open-chest dogs by direct assessment of myocardial radiotracer content, as well as those obtained noninvasively in vivo with PET, demonstrate that even with some restrictions to free diffusion, the permeability of H20 is sufficiently high to permit accurate measurement of myocardial blood flow. Since water injected intravenously circulates in the blood as well as diffuses into tissue, for PET, a method of visualization of H,150 in myocardium was developed whereby amount of labeled water in the region of interest could be corrected for radioactivity in blood within the same region with the use of a second tracer. Red blood cells, labeled in vivo with C'50, remain confined to the vascular space. The noninvasive method developed is rapid, can be employed sequentially, and should be suitable for application in patients.
Methods
Theoretical and mathematical basis of the method. For an inert, diffusible tracer, conservation of mass exists such that the rate of change in concentration of tracer in the tissue is equal to the rate of tracer entering the tissue minus the rate of tracer leaving the tissue5-' with respect to tissue volume. Thus dCT/dt = F (Ca -C) (1) where CT = tissue tracer concentration (counts/g); F = flow per unit of tissue (ml/g/min); Ca = arterial concentration of tracer (counts/ml); C, = venous concentration of tracer (counts/ ml).
Kety7 described the relationship of venous concentration of tracer to the tissue concentration of tracer by:
(Ca -C) = m(Ca -CT/?`) (2) where k = tissue/blood partition coefficient (ml/g); m = a diffusion constant reflecting effects of diffusion limitations and all other factors tending to limit equilibration of tracer between tissue and blood and defined by m = 1 -e -PS/F) (3) where PS = product of capillary permeability and surface area (ml/g/min), as follows: PS = -F ln(l -E)
where E = the extraction fraction of tracer. 22 23 E can be mathematically defined as 1 -e-pSF. Thus, E = m (equation 3). 16 By combining equations, we obtain dCT/dt = k (XCa -CT) where k is defined as k = mF/k (5) (6) By substitution and integration, the tissue concentration of CT at time T is CT(T) =k J Ca(t)e[ kIT -)Idt (7) Kety7 modeled the concentration of tracer in a region of tissue by assuming that blood and tissue (including capillaries) act as one compartment, with the concentration of tracer in the tissue at time T given by equation 7. Ca(t) is the concentration of tracer in the arterial blood as a function of time.
Experimental determination of extraction fraction of water by the heart. To determine whether the extraction fraction of H2150 by the myocardium varied with flow, and to concomitantly calculate the permeability-surface area product per unit tissue for H2150, we measured the myocardial single-pass extraction fraction of water in 15 mongrel dogs that had been anesthetized with thiopental ( 12.5 mg/kg) and a-chloralose (60 mg/kg) and ventilated with room air. Permeability-surface area product was determined with equation 4.
In each dog, the heart was exposed by a lateral thoracotomy and elevated in a pericardial cradle. The left circumflex coronary artery was isolated near the origin of the left main coronary artery, and a 22-gauge catheter (Quick-Cath) was inserted. In some of the 15 dogs (n = 8) the marginal branch of the circumflex coronary artery was isolated and ligated to induce a region of ischemia. In other experiments dogs (n = 8) were given 1.0 mg/kg dipyridamole (a gift of Boehringer lngelheim, Ltd.; Ridgefield, CT) intravenously to augment coronary flow. Some dogs were subjected to both coronary ligation and dipyridamole to create a wide range of flow in a single animal. To determine extraction fraction, H2150 (0.3 ml, 4 mCi/ml) was injected as a bolus (in 1 sec) directly into the coronary artery. The injection was given by preloading the infusion catheter and administering the tracer with the use of a constant-flow roller pump to obviate variations that might be induced with hand injections. Since total circumflex flow was at least 40 ml/min, administration of tracer did not alter total coronary flow or pressure (measured in pilot experiments in which distal coronary arterial pressure was measured during tracer administration) by more than 5%. Radioactivity was assessed with a /3-probe that detected radioactivity in a field of view directly under the probe.24 In our previous study24 we demonstrated that the contribution of gamma radiation elicited from positron annihilation to the count rate observed by the probe was less than 5%. In the current study, repeat injections of H2150 with lead interposed over the 3-probe reduced count response to less than 4% (10 determinations). Thus, error due to scatter from gamma radiation was low. Since the half-life of H2150 is 2.1 min, background radioactivity was negligible before each administration of tracer in those dogs in which multiple injections were made. The probe was positioned over the distribution of the marginal branch of the circumflex coronary artery. The fractional extraction of water was determined by back-extrapolation of the monoexponential tail of the tracer time-activity curve. 20 [25] [26] [27] [28] Since
tissue/blood partition coefficient (m]/g); D = specific gravity of heart muscle (assumed to be 1.06).,9 flow in these studies was determined by calculating the monoexponential washout of water, as previously described) The tissue/blood partition coefficient (X) is a measurement of the ratio of concentration of tracer in the tissue to concentration of tracer in the blood at equilibrium. It was calculated from the known water contents of left ventricular myocardium (0.78 g H2O/g muscle) and of blood. Plasma water varies with hematocrit. Since measured systemic hematocrit ranged from 0.35 to 0.45, plasma water was taken as 0.80 g H,Olg blood (0.83 g HW0/ml blood with correction for blood density). Thus, a value for A' of 0.92 ml blood/g tissue was used in these studies. No attempt was made to correct for small vessel hematocrit changes. In addition, no correction was made for X in studies in which dipyridamole was used since pilot studies indicated no change in H1O content of tissue after administration of this drug. (specific activity of 3 mCi/ml) was infused intravenously at a constant rate of 7 ml/min. The arterial concentration of tracer as a function of time was determined by collecting samples from a free-flowing catheter positioned in the midthoracic aorta. Samples (approximate volume of 0.5 ml) were collected every 3 to 5 see. Exactly 1 min after the infusion of tracer was begun (and while it was being continued) the heart was excised rapidly. Six to 15 transmural myocardial samples of approximately 0.9 g each from both normal and ischemic regions were placed in preweighed vials. Radioactivity in tissue and blood samples were assayed in a Beckman gamma well counter within 20 (and usually within 15) min after excision of the hearts. Counts were corrected for physical decay of the H2,1O. Since the half-life of '5o is short (2.1 min myocardial samples from the ischemic area were counted first (since they had the lowest expected counts/g), followed by myocardium from normal regions and then blood. Samples were counted for 15 sec. In ischemic regions, counts from H,150 before decay and weight correction but after correction for 15Sr ranged from 425 to 12.925 counts/ min; in normal regions the range was from 646 to 7962 counts/ min and in blood (at 60 sec of infusion), from 38.518 to 54,007 counts/min.
After sufficient time had elapsed for complete decay of H2150, samples were recounted to assess activity due to 85Sr and myocardial blood flow was determined by the standard microsphere reference technique. Flow determined from the tissue content of radiolabeled water was calculated with the use of equation 7 with values for the constant, m, determined from the extraction fraction of H21-5 that had been defined experimentally. Since the results (see below) indicated that permeabilitysurface area product increased linearly with flow, m. calculated from equation 3, was constant. Correction was made for timing discrepancies related to flow rate and volume of the catheter used for arterial blood sampling. This was accomplished by predetermining the volume of the catheter and measuring the flow rate of the free-flowing catheter. Thus, the time delay of the appearance of blood from the aorta to the sampling tube was known and the arterial blood curve was corrected for the slight delay in the appearance time. This usually was on the order of 1 to 3 sec. Correction for catheter-induced 'smearing" was not performed.
Measurement A bolus of 30 to 50 mCi of H50 was given via a peripheral vein. After a 10 to 20 sec delay to allow for transit to the heart, a 40 see period of data collection from seven simultaneous transaxial planes was initiated in the high-resolution mode.
Since a fraction of HW90 resides in the blood in the field of view, to visualize HWsO in the myocardium. radioactivity emanating from the HW50 in the blood was corrected for by subtraction. After H, 1O activity had completely decayed. the vascular space was labeled by administering approximately 30 mCi C'50 (which binds avidly to hemoglobin) bv inhalation and. after 1 min to allow for equilibration, data were acquired for 300 sec.
H, 1OR0I H) OM1YO + H,5OB_Il) (9) where the subscripts of ROI. MYO, and BLD represent radioactivity in a myocardial region of interest, in myocardium. and in blood, respectively. Thus. To obtain the needed H5O/C`50 ratio in left ventricular blood, a midventricular slice in the heart was selected and a region of interest in the mid-left ventricular cavity was identified in the C50 scan. The Figure 1 depicts representative time-activity curves from one dog after injections under control conditions, after flow had been augmented by infusion of dipyridamole, and after coronary flow had been reduced by ligation of the marginal branch of the circumflex coronary artery. Under the conditions of the study, R,'s0 was highly extracted (extraction fraction averaging 96 5% at flows of 80 to 100 ml/100 g/min) during a single pass. This high level of extraction was seen over the entire range of flows evaluated ( 12 to 238 ml/100 g/min) ( figure 2, A) .
With the measured values for extraction fraction, permeability-surface area product was determined from equation 4. For this calculation, values of extraction fraction of 1.0 (100%) were set to 0.99 since the natural log of 0 is indeterminant. Permeability-surface area product was found to approximate 3.8 x myocardial blood flow -28 and to vary directionally with flow ( figure 2, B) .
Application of the Kety-Schmidt model to H21O. In nine experiments, H,'5O was infused at a constant rate for 1 min and hearts were excised rapidly. Myocardial blood flow was calculated from equation 7. Results were compared with those obtained with microspheres. The one-compartment Kety model slightly underestimated flow (r = .95, y = 0.83x + 6.6, n = 95 comparisons) ( figure 3, A) . Some of the scatter in the data may have resulted from the fact that although radioactivity in myocardial samples was assayed promptly (within 10 min) after excision of the heart, the interval represented up to five half-lives. Thus, a large correction factor was required to correct for physical decay of the isotope. However, despite the scatter in the data in aggregate, results from each individual animal were quite linear, with little scatter about the best-fit line ( figure 3, B) . Applications to PET. The feasibility of measuring regional myocardial blood flow with H, 15 and PET was tested in six dogs. . than the theoretical value of 3.0 promulgated by Ginsburg33 as characteristic of a flow-limited tracer and is consistent with observations by Yudilevich and Alvarez 22 The results of the present study indicate that single- is considerably easier than 1 'C-butanol to produce and its shorter half-life permits rapid sequential studies. Many potential sources of error must be considered in autoradiographic approaches to measurement of blood flow, including inhomogeneity of flow, uncertainty concerning the choice of k, differences in tissue H20 content (which may be especially important in evaluations of ischemia or reperfusion), and the timing and "smearing" of the arterial time-activity curve nec- As shown in figure 7 . the correlation between the tomographic distribution of L1)50 and that of`5Ga-labeled microspheres is a close one. In this study, Optimal application this approach to PET requires instrumentation that permits gating with respect to both the calrdiac and respiratory cycles for correction of motion artifact, count spillover. and partial volume efftects.53 -"1' Super PETT 1 a fast scanning toimograph developed to employ time-of-flight measurements and cturrently undergoing clinical testing at our institution should meet these requirements. The implementation of the method developed in this study in patients should facilitate objective, noninvasive, sequential evaluation of myocardial blood flow and its response to medical or surgical interventions designed to favorably augment nutritional perfusion.
